NCT06478290View on ClinicalTrials.gov

Pilot Assessment of the Safety of a Combination of Curcumin, Omega-3, and Vitamin D Supplements in ACPA+ Individuals

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

October 31, 2027

Conditions
Healthy Participants
Interventions
COMBINATION_PRODUCT

curcumin, omega-3, and vitamin D (COD)

Combination of curcumin, omega-3, and vitamin D supplements (COD). Theracurmin Double Strength/Natural Factors Canada 180 mg/day (oral, 3 tablets of 60 mg taken by mouth) Vitamin D: 2000 IU/day LipoMicel/Natural Factors Canada (oral, 1 tablet taken by mouth) Omega-3: 900 mg day (oral, 1 tablet taken by mouth)

Trial Locations (2)

R0B 1B0

Norway House Health Centre, Norway House

R3A 1R9

Health Sciences Centre, Winnipeg

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of Manitoba

OTHER

NCT06478290 - Pilot Assessment of the Safety of a Combination of Curcumin, Omega-3, and Vitamin D Supplements in ACPA+ Individuals | Biotech Hunter | Biotech Hunter